Sanofi-Aventis reacts to Ypsomed patent lawsuit

Press Releases Ypsomed Group

Burgdorf - SYpsomed has taken notice that Sanofi-Aventis has filed a lawsuit in Basel against Ypsomed AG and TecPharma Licensing AG in relation to the SoloStar injection system developed and manufactured by Sanofi-Aventis. The lawsuit claims certain license rights, which in the opinion of Sanofi-Aventis should be granted by Ypsomed.

Les mer …

Sanofi-Aventis confirms expected orders for 2008

Press Releases Ypsomed Group

Burgdorf - Sanofi-Aventis has confirmed the order volumes for calendar year 2008 for the successfully launched and established pen systems: OptiSet, OptiClik and OptiPen Pro. Richard Fritschi, Ypsomed CEO, is pleased: “The confirmed orders for 2008 by Sanofi-Aventis are within our expectations, but - as announced earlier - lower than in the past year.

Les mer …

Ypsomed concludes Licence Agreement on own autoinjector patents with Cilag GmbH International

Press Releases Ypsomed Group

Burgdorf - Ypsomed is pleased to announce that it has granted to Cilag GmbH International, a non exclusive licence to use certain patents, which protect inventions of Ypsomed, for an autoinjector device for the administration of two biopharmaceutical products with an option to extend the licence for a number of other compounds. Ypsomed is not in a position to communicate the commercial details of the agreement, but expects to receive significant royalties over the term of the contract.

Les mer …

Change in responsibilities of production at Ypsomed

Press Releases Ypsomed Group

Burgdorf - Ypsomed announces that Christoph Brand, Senior Vice President Production & Logistics and member of the Executive Management team leaves the company. Chief Operating Officer Maurice Meytre will take over this responsibility. With immediate effect Hansueli Lehmann as Head of the Solothurn Production site, Benjamin Reinmann as Head of the Burgdorf Production site und Ueli Bracher as Head of Logistics will report directly to Maurice Meytre.

Les mer …

Ypsomed files a breach of patent lawsuit against Sanofi-Aventis

Press Releases Ypsomed Group

Burgdorf - Ypsomed filed a lawsuit against Sanofi-Aventis in Germany. Ypsomed believes that the SoloStar injection system developed and manufactured by Sanofi-Aventis is in breach of its own patents. Sanofi-Aventis uses the SoloStar pen for administration of its Lantus and Apidra insulin products.

Les mer …